Dysregulation of the lncRNA Snhg12 is involved in a variety of pathogeneses, such as those of LDL-induced endothelial cell injury in atherosclerosis (Mao et al., 2021) and endometrial (Cai et al., 2021), gastric (Zhang T. et al., 2021), and hepatocellular cancer (Zhang Q. et al., 2021). This evidence concerns the gene SNHG12 and hepatocellular carcinoma.